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Treatment changes are typical in epilepsy because of the
chronic nature of the disease and common problems
with treatment, most typically inadequate seizure con-
trol and unacceptable adverse effects. Randomised trials
in epilepsy often adopt a pragmatic approach to treat-
ment changes, in order to cater for patient needs and
mirror the real-life experience of patients. Trial patients
may experience multiple treatment changes taking a
variety of forms, including addition of alternative treat-
ment(s), switching to other treatment(s) and complete
withdrawal from all treatment.
Primary analysis of trial data is usually based on the
principle of intention to treat (ITT), which ignores such
treatment changes and thus avoids any selection bias
that may be introduced by changes from randomised
treatment. ITT however only allows estimation of the
effectiveness of treatment, rather than the true efficacy
(or causal effect) of treatment, which is of particular
interest to patients and clinicians alike in this setting.
Methods such as per protocol or as treated analyses are
commonly implemented to estimate causal effects, but
are often biased because treatment changes are typically
associated with prognostic factors. There exist alternative
statistical methods to estimate causal effects of treatment
whilst avoiding such bias, such as the rank preserving
structural failure time model (RPSTFM) and inverse
probability of censoring weighting (IPCW) models, but
these methods are not well known and require certain
assumptions. I will discuss the challenges of adjusting for
treatment changes in epilepsy and demonstrate the
RPSTFM and IPCW methods, discussing their advantages
and disadvantages in this setting.
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